Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.28% is 69% below its 5-year average of 4.07%, near the low end of its 5-year range (0.12%–9.03%).
As of the fiscal period ended Tuesday, June 30, 2026. 21.26% below its 12-month average of 1.62%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.28%.
DEBT TO ASSETS RATIO
1.28%
DEBT TO ASSETS RATIO AVG TTM
1.62%
DEBT TO ASSETS RATIO AVG 3Y
4.94%
DEBT TO ASSETS RATIO AVG 5Y
4.07%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-21.26%
CURRENT VS 3Y AVG
-74.10%
CURRENT VS 5Y AVG
-68.58%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+1321.04%
vs the sector median at left
Strata Critical Medical, Inc.
Market Cap
$411.00M
Debt to Assets Ratio
1.28%
TTM Avg
1.62%
3Y Avg
4.94%
5Y Avg
4.07%
Market Cap
$411.21M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$406.58M
Debt to Assets Ratio
0.32%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$405.74M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.27M
Debt to Assets Ratio
0.35%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$404.24M
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$418.95M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Strata Critical Medical, Inc. (SRTA) | $411.00M | 1.28% | 1.62% | 4.94% | 4.07% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 0.01% | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | 0.32% | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 0.01% | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | 0.00% | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 0.35% | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | 0.33% | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | 0.07% | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $402.17M | 0.03% | N/A | N/A | N/A |
| Prothena Corporation plc (PRTA)vs › | $419.87M | 0.02% | N/A | N/A | N/A |
Debt/Assets
1.3%
Debt/Equity
0.02
Current Ratio
2.64
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.28% |
| 2026-03-31 | 1.36% |
| 2025-12-31 | 1.02% |
| 2025-09-30 | 1.04% |
| 2025-06-30 | 3.43% |
| 2025-03-31 | 3.62% |
| 2024-12-31 | 3.63% |
| 2024-09-30 | 8.39% |
| 2024-06-30 | 7.85% |
| 2024-03-31 | 9.03% |
| 2023-12-31 | 8.32% |
| 2023-09-30 | 7.67% |
| 2023-06-30 | 7.56% |
| 2023-03-31 | 7.70% |
| 2022-12-31 | 5.64% |
| 2022-09-30 | 5.25% |
| 2022-06-30 | 1.89% |
| 2022-03-31 | 0.29% |
| 2021-12-31 | 0.19% |
| 2021-09-30 | 0.21% |
| 2021-06-30 | 0.12% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 10.65% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.17% |
| 2019-09-30 | 0.08% |
